Optimum management of glucocorticoid-treated patients.

作者: Subbulaxmi Trikudanathan , Graham T McMahon

DOI: 10.1038/NCPENDMET0791

关键词:

摘要: Glucocorticoids are taken by approximately 2% of the US adult population at any given time. The powerful anti-inflammatory and immunosuppressive benefits these drugs must, however, be weighed against their multisystem adverse effects. Clinicians should always prescribe lowest possible dose for shortest Patients informed short-term long-term effects to expect, particularly if glucocorticoids is expected exceed equivalent 7.5 mg prednisone daily 2 months or more. At commencement glucocorticoid therapy, a patient's blood pressure, lipid profile, 25-hydroxyvitamin D(3) level fasting glucose measured baseline bone densitometry performed. Bisphosphonate therapy initiated postmenopausal women men with density T-score below -1 those history fracture. Regular ophthalmic screening cataracts glaucoma warranted, patients high-risk gastric ulceration (especially simultaneously taking nonsteroidal drugs) receive proton-pump inhibitors. Prophylaxis opportunistic infections appropriate populations, such as organ-transplant recipients. Trimethoprim plus sulfamethoxazole can organ transplant duration weaning from treatment proportionate duration. Appropriate preventive mitigate many associated therapy.

参考文章(111)
J Sibley, M Haga, A Russell, R McDougall, Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. The Journal of Rheumatology. ,vol. 21, pp. 1207- 1213 ,(1994)
F M Hankin, J F Eckenrode, D S Louis, Cutaneous atrophy after corticosteroid injection American Family Physician. ,vol. 33, pp. 183- 186 ,(1986)
Michael B. Jacobs, Local subcutaneous atrophy after corticosteroid injection Postgraduate Medicine. ,vol. 80, pp. 159- 160 ,(1986) , 10.1080/00325481.1986.11699543
W. Hofstetter, H. Silberman, B. Hopkins, D. Garner, T. Noonan, G. Anthony, A. Brant, M.B. Calobrace, Parakrama Chandrasoma, D. Greenwald, Vanna Soonthon, W. Raboff, L. Labree, Mesh reinforcement increases bursting strength of intestinal anastomoses in steroid-treated rabbits. American Surgeon. ,vol. 60, pp. 721- 727 ,(1994)
J J Greenberg, P B Dobrin, F J Harford, R L Gamelli, T R Eubanks, The effects of different corticosteroids on the healing colon anastomosis and cecum in a rat model. American Surgeon. ,vol. 63, pp. 266- 269 ,(1997)
M. T. Falduto, A. P. Young, R. C. Hickson, Exercise interrupts ongoing glucocorticoid-induced muscle atrophy and glutamine synthetase induction. American Journal of Physiology-endocrinology and Metabolism. ,vol. 263, ,(1992) , 10.1152/AJPENDO.1992.263.6.E1157
S M Davis, J C Cline, Risks of infection or reactivation of tuberculosis associated with chronic corticosteroid therapy. Annals of Pharmacotherapy. ,vol. 31, pp. 775- 776 ,(1997)
C. M. Pariante, Charles Nemeroff, A. H. Miller, Glucocorticoid receptors in depression. Israel journal of medical sciences. ,vol. 31, pp. 705- 712 ,(1995)
Patricia G Pecora, Barbara Kaplan, Corticosteroids and ulcers: is there an association? Annals of Pharmacotherapy. ,vol. 30, pp. 870- 872 ,(1996) , 10.1177/106002809603000729